SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla shares are facing volatility as the market reacts to a Cybercab launch event that many retail traders described as underwhelming due to a lack of a public livestream, limited deployment details, and unresolved regulatory scrutiny. While some investors remain bullish on the long-term potential of the robotaxi network, others are criticizing the event as a "sell-the-news" catalyst, pointing to concerns over production costs, safety, and leadership communication.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares dropped significantly after the company reported disappointing quarterly results, missed revenue expectations, and issued a weakened full-year outlook. While some traders view the decline as a "fat pitch" opportunity for a long-term turnaround under incoming leadership, many others are bearish, citing deteriorating brand heat, increased competition, and concerns that the company's premium pricing is unsustainable in the current economy.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending following a report that China is blocking rare earth shipments to the U.S., fueling concerns about supply chain security and reinforcing the company's position as a critical domestic supplier. The stock is also being discussed in light of the recently completed merger with Serra Verde Group, which investors see as a strategic milestone for expanding U.S.-based rare earth production.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is seeing significant momentum and heightened attention as traders react to a sustained price rally and the launch of a Zcash ETF on the NYSE. While many in the community are bullish on its long-term potential as a privacy-focused asset, others warn of volatility and profit-taking after the rapid price increase.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler stock is under pressure as traders express frustration over decelerating organic revenue growth and guidance, despite a recent earnings beat and multiple analyst price target increases. The conversation is dominated by debate over the company's valuation compared to cybersecurity peers and concerns about management's guidance strategy.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is receiving significant attention following a strong fiscal second-quarter report that featured record revenue, double-beat earnings, and an improved full-year outlook. Traders are actively debating the company's long-term growth potential in defense and geospatial intelligence against concerns regarding softer third-quarter guidance and ongoing capital expenditure.

Samsara, Inc. develops internet connected sensor systems. It combines plug-and-play sensors, wireless connectivity, and cloud-hosted software integrated for deployment. The company was founded by John Bicket and Sanjit Biswas in 2015 and is headquartered in San Francisco, CA.

Samsara Inc - Ordinary Shares - Class A

Samsara Inc

Samsara is trending following a "double beat and raise" fiscal second-quarter report, where both earnings and revenue significantly surpassed analyst expectations. Investors are reacting positively to the company's accelerated annualized recurring revenue (ARR) growth and raised full-year outlook, which analysts attribute to strong momentum in large-customer adoption and continued cross-selling of emerging products.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is trending as traders speculate on a potential upcoming inclusion in the S&P 500 index during the next rebalancing. Community discussion is heavily focused on the stock's price action and the impact of institutional buying, with many participants debating the merits of long-term holding versus short-term volatility.

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

DocuSign Inc

DocuSign is trending after reporting better-than-expected fiscal second-quarter revenue and earnings, which led several analysts to raise their price targets. While some traders expressed bullishness over the company's progress with its AI-powered Intelligent Agreement Management (IAM) platform, others remained skeptical, citing concerns about competition from free alternatives and the stock's long-term growth outlook.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath shares fell after fiscal second-quarter results prompted mixed reactions, as traders weighed a revenue and guidance beat against concerns over narrowing gross margins and a lack of accelerated growth from agentic AI. While retail sentiment remains largely bullish with many viewing the dip as a temporary shakeout driven by institutional option activity and short-interest dynamics, some analysts and traders expressed skepticism regarding the pace of AI-driven ARR growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NRX Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript

NRX Pharmaceuticals (NASDAQ:NRXP) released second-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below.
This content is powered by Benzinga APIs. For comprehensiveread more...

NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates

NRx Pharmaceuticals (NRXP) delivered earnings and revenue surprises of -100.00% and -54.13%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

NRx Pharmaceuticals Inches Toward Approval After FDA Finds No Drug Deficiencies

NRx Pharmaceuticals (NASDAQ:NRXP) reached a potentially significant regulatory milestone after announcing that the U.S. Food and Drug Administration completed its first-cycle review of the company's Abbreviated New Drug Application (ANDA) for preservative-free intravenous ketamine without identifying any major deficiencies related to the drug itself. Instead, the remaining review item involves certification of the product's luer lock vial packaging, a manufacturing documentation issue rather than concerns involving safety, efficacy, labeling, chemistry, manufacturing controls, or the ketamine formulation.

ZETA SURGICAL Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics

ZETA SURGICAL Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics ZETA SURGICAL Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics PR Newswire SARASOTA, Fla, and BOSTON, June 23, 2026 SARASOTA, Fla...

NRx Pharmaceuticals (NRXP) Stock Fell 19% After Hours On Tuesday: Here's Why

NRXP stock fell after hours after NRx Pharmaceuticals announced a public stock offering to raise capital for growth and operations.read more...

NRx Pharmaceuticals, Inc. (NRXP) Reports Q1 Loss, Lags Revenue Estimates

NRx Pharmaceuticals (NRXP) delivered earnings and revenue surprises of +20.00% and -91.28%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

NRx Pharma (NRXP) set to release Q1 earnings on May 18. Analysts expect $19.43 million in revenue, with a loss of 11 cents per share. FDA clearance received for clinical trial.read more...

D. Boral Capital Reaffirms Buy Rating for NRx Pharmaceuticals (NASDAQ:NRXP)

D. Boral Capital restated a 'buy' rating and issued a $34.00 price objective on shares of NRx Pharmaceuticals in a research note on Tuesday...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Sees Large Growth in Short Interest

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling...

Equities Analysts Offer Predictions for NRXP Q1 Earnings

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Free Report) - Research analysts at HC Wainwright issued their Q1 2027 earnings estimates for NRx Pharmaceuticals in a note issued to investors on Monday...

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.

NRX Pharmaceuticals Inc

Why Did NRXP Stock Surge 21% Pre-Market Today?

Equity

Bearish Sentiment

The Federal Reserve hasn't raised rates at all in 2026, but hawkish comments from Fed Chair Kevin Warsh at the Jackson Hole symposium have pushed September rate hike odds as high as 66%, a sharp jump from under 40% just a week earlier. How many rate hikes do you expect from the Fed in 2026? Vote and explain your reasoning in the comments.

How many rate hikes do you expect from the Fed in 2026?

Current Price	$3.43
Prev Close	$3.46
Open	$3.48
Dividend Yield	0.00%
50-Day Moving Average	$3.68
Beta	1.28
Avg. Volume	1.15M
PE Ratio	-4.66

52-Week High	$5.06
52-Week Low	$1.62
Market Capitalization	$148.5M
EPS (Annual)	-$1.34
Price to Book	-870.56
Revenue Per Employee	$42,241.38

Feed

News

Sentiment

Earnings

Fundamentals

Info

NRXP Fundamentals